Armistice Capital LLC Sells 552,000 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)

Armistice Capital LLC cut its stake in shares of Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 5.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,672,000 shares of the company’s stock after selling 552,000 shares during the period. […]

Related Keywords

,Ci Private Wealth ,Renaissance Technologies ,Sei Investments Co ,Armistice Capital ,Exchange Commission ,Nasdaq ,Autolus Therapeutics ,Free Report ,Sigma Advisers ,Street Group ,Sei Investments ,Get Free Report ,Truist Financial ,Visit Holdingschannel ,Autolus Therapeutics Daily ,Nasdaq Autl ,Autl ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,